Archive | January, 2021
Congratulations to KemPharm, Inc. on the Uplisting to The Nasdaq Capital Market and $50 million public offering led by ROTH Capital Markets!
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market January 8, 2021 at 8:30 AM EST Common stock will begin trading on The Nasdaq Capital Market under the ticker symbol “KMPH” today, January 8, 2021 CELEBRATION, Fla., Jan. 08, 2021 (GLOBE NEWSWIRE) — KemPharm, […]